| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |